Yi Li Selected Research

Carcinogenesis

6/2024	STAT6-targeting antisense oligonucleotides against solitary fibrous tumor.
4/2024	Characterization of the malignant cells and microenvironment of infantile fibrosarcoma via single-cell RNA sequencing.
11/2023	ECM1 promotes migration and invasion in endometriosis.
11/2023	Downregulation of Claudin5 promotes malignant progression and radioresistance through Beclin1-mediated autophagy in esophageal squamous cell carcinoma.
8/2023	The Active Fraction of Polyrhachis vicina Roger (AFPR) activates ERK to cause necroptosis in colorectal cancer.
8/2023	MiR-4524b-5p-targeting ALDH1A3 attenuates the proliferation and radioresistance of glioblastoma via PI3K/AKT/mTOR signaling.
12/2022	Single-cell transcriptional profiling reveals heterogeneity and developmental trajectories of Ewing sarcoma.
8/2022	RNA Editing Enzyme ADAR1 Regulates METTL3 in an Editing Dependent Manner to Promote Breast Cancer Progression via METTL3/ARHGAP5/YTHDF1 Axis.
1/2022	Evolving Insights Into the Biological Function and Clinical Significance of Long Noncoding RNA in Glioblastoma.
1/2022	RNA demethylase ALKBH5 promotes tumorigenesis in multiple myeloma via TRAF1-mediated activation of NF-κB and MAPK signaling pathways.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yi Li Research Topics

Disease

651	Neoplasms (Cancer) 05/2024 - 04/2002
173	Inflammation (Inflammations) 05/2024 - 07/2006
148	Infections 12/2024 - 08/2002
113	Breast Neoplasms (Breast Cancer) 02/2024 - 04/2002
112	Stroke (Strokes) 03/2024 - 01/2002
100	Neoplasm Metastasis (Metastasis) 03/2024 - 04/2002
65	Hemorrhage 04/2024 - 04/2006
59	Carcinoma (Carcinomatosis) 11/2023 - 04/2002
58	Carcinogenesis 06/2024 - 12/2003
58	Thrombosis (Thrombus) 02/2024 - 11/2004
56	Alzheimer Disease (Alzheimer's Disease) 05/2024 - 04/2006
53	Crohn Disease (Crohn's Disease) 01/2024 - 01/2009
52	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 04/2006
48	Hypoxia (Hypoxemia) 12/2024 - 01/2012
47	Acute Coronary Syndrome 04/2024 - 08/2006
46	Ischemia 01/2024 - 01/2002
45	Lung Neoplasms (Lung Cancer) 04/2024 - 04/2002
45	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 08/2002
42	Necrosis 03/2024 - 06/2011
41	Sepsis (Septicemia) 01/2024 - 08/2002
39	Myocardial Infarction 04/2024 - 03/2011
39	Body Weight (Weight, Body) 02/2024 - 09/2007
38	Colorectal Neoplasms (Colorectal Cancer) 09/2023 - 04/2002
37	COVID-19 05/2024 - 01/2020
37	Fibrosis (Cirrhosis) 08/2023 - 08/2007
37	Hypertension (High Blood Pressure) 06/2023 - 07/2009
35	Colitis 12/2023 - 09/2010
34	Pain (Aches) 05/2024 - 08/2005
31	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 02/2003
30	Cognitive Dysfunction 05/2024 - 12/2008
30	Virus Diseases (Viral Diseases) 05/2024 - 12/2007
30	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 04/2003
29	Stomach Neoplasms (Stomach Cancer) 04/2024 - 11/2007
28	Wounds and Injuries (Trauma) 04/2024 - 07/2006
27	Ischemic Stroke 04/2024 - 02/2012
27	Urinary Bladder Neoplasms (Bladder Cancer) 12/2023 - 12/2011
27	Poisoning 12/2023 - 10/2006
26	Squamous Cell Carcinoma of Head and Neck 01/2023 - 01/2004
26	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2023 - 04/2002
25	Glioma (Gliomas) 03/2024 - 03/2008
25	Heart Failure 03/2024 - 05/2009
24	Type 2 Diabetes Mellitus (MODY) 11/2023 - 06/2005
23	Head and Neck Neoplasms (Head and Neck Cancer) 02/2024 - 01/2003
23	Nasopharyngeal Carcinoma 11/2023 - 09/2008
22	Atherosclerosis 06/2024 - 01/2008
22	Coronary Artery Disease (Coronary Atherosclerosis) 12/2023 - 04/2006
22	Schizophrenia (Dementia Praecox) 11/2023 - 04/2006
21	Reperfusion Injury 04/2024 - 06/2004
21	Rheumatoid Arthritis 01/2024 - 12/2009
21	Insulin Resistance 11/2023 - 07/2006
20	Multiple Myeloma 05/2024 - 07/2009

Drug/Important Bio-Agent (IBA)

282	Proteins (Proteins, Gene)FDA Link 06/2024 - 08/2002
156	Biomarkers (Surrogate Marker)IBA 05/2024 - 01/2005
78	CytokinesIBA 05/2024 - 05/2008
70	MicroRNAs (MicroRNA)IBA 03/2024 - 07/2007
65	Therapeutic UsesIBA 12/2024 - 08/2002
59	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 06/2006
55	Messenger RNA (mRNA)IBA 03/2024 - 04/2002
45	DNA (Deoxyribonucleic Acid)IBA 06/2024 - 06/2004
44	Cisplatin (Platino)FDA LinkGeneric 04/2024 - 01/2004
41	RNA (Ribonucleic Acid)IBA 04/2024 - 01/2008
37	LipidsIBA 02/2024 - 07/2006
36	Small Interfering RNA (siRNA)IBA 01/2024 - 08/2008
35	AntigensIBA 04/2024 - 04/2003
34	Clopidogrel (Plavix)FDA Link 04/2024 - 08/2006
33	Anti-Bacterial Agents (Antibiotics)IBA 03/2024 - 06/2005
33	LipopolysaccharidesIBA 02/2024 - 06/2013
32	LigandsIBA 04/2024 - 11/2006
32	Interleukin-6 (Interleukin 6)IBA 04/2024 - 08/2002
32	EnzymesIBA 02/2024 - 07/2002
31	Peptides (Polypeptides)IBA 02/2024 - 08/2002
30	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2024 - 01/2011
30	C-Reactive ProteinIBA 04/2024 - 04/2003
30	Transcription Factors (Transcription Factor)IBA 04/2024 - 09/2007
30	Long Noncoding RNAIBA 01/2024 - 01/2015
29	VaccinesIBA 12/2024 - 04/2003
29	Interleukin-10 (Interleukin 10)IBA 11/2022 - 05/2008
28	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2024 - 08/2003
25	AntioxidantsIBA 04/2024 - 01/2007
25	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2024 - 04/2003
24	PolymersIBA 06/2024 - 08/2008
24	Indicators and Reagents (Reagents)IBA 05/2024 - 07/2007
24	AlbuminsIBA 01/2024 - 04/2013
24	Hormones (Hormone)IBA 01/2024 - 07/2010
23	CreatinineIBA 12/2024 - 01/2009
23	Oxygen (Dioxygen)IBA 08/2023 - 06/2006
23	salicylhydroxamic acid (SHAM)IBA 01/2023 - 11/2009
22	AntibodiesIBA 03/2024 - 01/2002
22	omega-Chloroacetophenone (Mace)IBA 01/2023 - 04/2006
21	Phosphotransferases (Kinase)IBA 01/2024 - 04/2005
20	Amyloid (Amyloid Fibrils)IBA 05/2024 - 03/2011
20	Immune Checkpoint InhibitorsIBA 04/2024 - 01/2019

Therapy/Procedure

367	Therapeutics 06/2024 - 04/2002
101	Drug Therapy (Chemotherapy) 03/2024 - 04/2002
87	Radiotherapy 04/2024 - 01/2003
56	Stents 10/2023 - 04/2005
52	Immunotherapy 04/2024 - 07/2007
45	Percutaneous Coronary Intervention 04/2024 - 07/2006
34	Aftercare (After-Treatment) 04/2024 - 04/2004
27	Transplantation 12/2024 - 07/2002